{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-016085","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2022-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.411032+00:00","generated_at":"2026-06-24T02:20:51.320598+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LifeStance Q2 revenue $209.5M (+31%); net loss $68.7M; lowers FY revenue guidance to bottom of $865-885M range","bullets":["Revenue $209.5M, +31% YoY; net loss $68.7M (incl $57.5M stock comp).","Adjusted EBITDA $14.6M flat YoY; Center Margin $59.8M (28.5% of rev).","Clinicians 5,226 (+31%); net add 237 in Q2; 4 acquisitions closed.","FY2022 rev guidance lowered to bottom of $865-885M; Adj. EBITDA reaffirmed $63-67M; Q3 rev $216-221M.","Danish Qureshi appointed COO effective July 1; OBIE online booking live in 9 states."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-016085","json":"https://secwatch.observer/filing/0000950170-22-016085.json","markdown":"https://secwatch.observer/filing/0000950170-22-016085.md","text":"https://secwatch.observer/filing/0000950170-22-016085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/0000950170-22-016085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017022016085/lfst-20220809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:20:51.320598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}